Asaf Madi

About Asaf Madi

Asaf Madi, With an exceptional h-index of 32 and a recent h-index of 27 (since 2020), a distinguished researcher at Tel Aviv University, specializes in the field of Systems Immunology, Tumor Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods and compositions targeting glucocorticoid signaling for modulating immune responses

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

A PD1-antibody-attenuated IL-2 fusion protein activates immune cells leading to the inhibition of tumor growth in ex vivo human 3D tumor models

P-selectin as an emerging target for the treatment of primary and secondary brain tumors

Beyond IL-2: The promise of anti PD-1-attenuated IL-2 fusion protein in cancer immunotherapy

Eosinophils exhibit a unique transcriptional signature and increased sensitivity to IL-3-induced activation in response to colorectal cancer cells

Deep Proteomic Analysis Reveals Shared Terminal Mechanisms for Familial Hemophagocytic Lymphohistiocytosis and Lymphoma-Associated Hyperinflammation

Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation

Asaf Madi Information

University

Position

___

Citations(all)

6043

Citations(since 2020)

4836

Cited By

2977

hIndex(all)

32

hIndex(since 2020)

27

i10Index(all)

41

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Asaf Madi Skills & Research Interests

Systems Immunology

Tumor Immunology

Top articles of Asaf Madi

Methods and compositions targeting glucocorticoid signaling for modulating immune responses

2024/4/16

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Advanced Functional Materials

2024/4/1

João Conniot
João Conniot

H-Index: 7

Asaf Madi
Asaf Madi

H-Index: 21

A PD1-antibody-attenuated IL-2 fusion protein activates immune cells leading to the inhibition of tumor growth in ex vivo human 3D tumor models

Cancer Research

2024/3/22

P-selectin as an emerging target for the treatment of primary and secondary brain tumors

Cancer Research

2024/3/22

Beyond IL-2: The promise of anti PD-1-attenuated IL-2 fusion protein in cancer immunotherapy

Cancer Research

2024/3/22

Eosinophils exhibit a unique transcriptional signature and increased sensitivity to IL-3-induced activation in response to colorectal cancer cells

Journal of Leukocyte Biology

2024/3/13

Ariel Munitz
Ariel Munitz

H-Index: 24

Asaf Madi
Asaf Madi

H-Index: 21

Deep Proteomic Analysis Reveals Shared Terminal Mechanisms for Familial Hemophagocytic Lymphohistiocytosis and Lymphoma-Associated Hyperinflammation

Blood

2023/11/28

Asaf Madi
Asaf Madi

H-Index: 21

Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation

Nature Immunology

2023/11

interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptors

2023/10/31

Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis

2023/10/24

Viral infection reveals hidden sharing of TCR CDR3 sequences between individuals

Frontiers in Immunology

2023/5/30

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors

Cancer Cell

2023/2/13

Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage

Nature biotechnology

2022/12

Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy

Elife

2022/9/20

MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression

JCI insight

2022/9/9

Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity

Brain

2022/9/1

A hierarchy of selection pressures determines the organization of the T cell receptor repertoire

Frontiers in immunology

2022/7/29

FLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptors

2022/6/29

Roded Sharan
Roded Sharan

H-Index: 46

Asaf Madi
Asaf Madi

H-Index: 21

Identification of factors mediating the signaling convergence of multiple receptors following cell-cell interaction

bioRxiv

2022/6/29

Roded Sharan
Roded Sharan

H-Index: 46

Asaf Madi
Asaf Madi

H-Index: 21

Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells

Nature Immunology

2022/4

See List of Professors in Asaf Madi University(Tel Aviv University)